...
首页> 外文期刊>BMC Nephrology >Factors associated with adverse outcomes from cardiovascular events in the kidney transplant population: an analysis of national discharge data, hospital characteristics, and process measures
【24h】

Factors associated with adverse outcomes from cardiovascular events in the kidney transplant population: an analysis of national discharge data, hospital characteristics, and process measures

机译:肾移植人群中心血管事件与不良后果相关的因素:国家出院数据,医院特征和处理措施的分析

获取原文
           

摘要

Kidney transplant (KT) patients presenting with cardiovascular (CVD) events are being managed increasingly in non-transplant facilities. We aimed to identify drivers of mortality and costs, including transplant hospital status. Data from the 2009–2011 Nationwide Inpatient Sample, the American Hospital Association, and Hospital Compare were used to evaluate post-KT patients hospitalized for MI, CHF, stroke, cardiac arrest, dysrhythmia, and malignant hypertension. We used generalized estimating equations to identify clinical, structural, and process factors associated with risk-adjusted mortality and high cost hospitalization (HCH). Data on 7803 admissions were abstracted from 275 hospitals. Transplant hospitals had lower crude mortality (3.0% vs. 3.8%, p?=?0.06), and higher un-adjusted total episodic costs (Median $33,271 vs. $28,022, p??0.0001). After risk-adjusting for clinical, structural, and process factors, mortality predictors included: age, CVD burden, CV destination hospital, diagnostic cardiac catheterization without intervention (all, p??0.001). Female sex, race, documented co-morbidities, and hospital teaching status were protective (all, p??0.05). Transplant and non-transplant hospitals had similar risk-adjusted mortality. HCH was associated with: age, CVD burden, CV procedures, and staffing patterns. Hospitalizations at transplant facilities had 37% lower risk-adjusted odds of HCH. Cardiovascular process measures were not associated with adverse outcomes. KT patients presenting with CVD events had similar risk-adjusted mortality at transplant and non-transplant hospitals, but high cost care was less likely in transplant hospitals. Transplant hospitals may provide better value in cardiovascular care for transplant patients. These data have significant implications for patients, transplant and non-transplant providers, and payers.
机译:出现心血管事件(CVD)的肾移植(KT)患者正在非移植设施中得到越来越多的管理。我们旨在确定死亡率和成本的驱动因素,包括移植医院的状况。使用2009-2011年全国住院患者样本,美国医院协会和Hospital Compare的数据评估因心肌梗死,CHF,中风,心脏骤停,心律不齐和恶性高血压而住院的KT后患者。我们使用广义估计方程来确定与风险调整后的死亡率和高成本住院(HCH)相关的临床,结构和过程因素。从275家医院中提取了7803例入院数据。移植医院的粗死亡率较低(3.0%vs. 3.8%,p = 0.06)和未调整的总体医疗费用较高(中位数为$ 33,271 vs. $ 28,022,p 0.0001)。在对临床,结构和过程因素进行风险调整后,死亡率预测因素包括:年龄,CVD负担,简历目的地医院,无需干预的诊断性心脏导管插入术(全部,p <0.001)。女性,种族,已记录的合并症和医院教学状况均具有保护性(全部,p≤0.05)。移植医院和非移植医院的风险调整后死亡率相似。六氯环己烷与年龄,CVD负担,简历程序和人员配置方式有关。移植设施住院的六氯环己烷风险调整后几率降低了37%。心血管过程指标与不良结局无关。出现CVD事件的KT患者在移植医院和非移植医院的风险调整后死亡率相似,但是在移植医院进行高成本护理的可能性较小。移植医院可以为移植患者提供更好的心血管护理价值。这些数据对患者,移植和非移植提供者以及付款人具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号